INVESTMENTS IN CONSOLIDATED AND UNCONSOLIDATED ENTITIES - Summarized Statements of Operations of Unconsolidated Entities Accounted by Equity Method (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Schedule of Equity Method Investments [Line Items]
Revenues	$ 1,675,545	$ 2,034,644	$ 5,397,966	$ 5,732,791
Costs and expenses	(1,283,827)	(1,476,704)	(4,106,997)	(4,240,243)
Net income/(loss) from unconsolidated entities	1,934	(1,180)	7,049	(2,986)
Distributions to TMHC from unconsolidated entities			7,377	5,318
Equity Method Investments
Schedule of Equity Method Investments [Line Items]
Revenues	44,010	25,495	95,647	150,062
Costs and expenses	(37,810)	(27,310)	(76,575)	(145,238)
Net income/(loss) from unconsolidated entities	6,200	(1,815)	19,072	4,824
TMHC's share in net income/(loss) of unconsolidated entities	1,934	(1,180)	7,049	(2,986)
Distributions to TMHC from unconsolidated entities	$ 2,226	$ 10,006	$ 8,110	$ 100,835